Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

3.4.21.97: assemblin

This is an abbreviated version!
For detailed information about assemblin, go to the full flat file.

Word Map on EC 3.4.21.97

Reaction

Cleaves -Ala-/-Ser- and -Ala-/-Ala- bonds in the scaffold protein =

Synonyms

Assemblin, assembly protein precursor-processing proteinase, capsid scaffolding protein, cytomegalovirus protease, cytomegalovius maturational protease, cytomeglovirus protease, HCMV protease, Herpes simplex virus 1 proteinase Pra, Herpes simplex virus endopeptidase, HHV-6 proteinase, hMCV, HSV 1 protease, HSV-1, HSV-1 protease, HSV-2, human cytomegalovirus maturational protease, human cytomegalovirus maturational proteinase, human cytomegalovirus protease, human cytomegalovirus proteinase, maturation proteinase, proteinase, assembly protein precursor-processing, pUL80a, SFA, Varicella-zoster virus gene 33 proteinase

ECTree

     3 Hydrolases
         3.4 Acting on peptide bonds (peptidases)
             3.4.21 Serine endopeptidases
                3.4.21.97 assemblin

Inhibitors

Inhibitors on EC 3.4.21.97 - assemblin

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(2S)-2-[[(3aS,6S,6aR)-4-(1,3-benzothiazol-2-yl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00018 mM
(2S)-2-[[(3aS,6S,6aR)-4-(4-chloro-1,3-benzothiazol-2-yl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00029 mM
(2S)-2-[[(3aS,6S,6aR)-4-(4-methoxy-1,3-benzothiazol-2-yl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00024 mM
(2S)-2-[[(3aS,6S,6aR)-4-(4-methoxy-7-methyl-1,3-benzothiazol-2-yl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]-pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.0011 mM
(2S)-2-[[(3aS,6S,6aR)-4-(5-chloro-1,3-benzothiazol-2-yl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00046 mM
(2S)-2-[[(3aS,6S,6aR)-4-(5-methoxy-1,3-benzothiazol-2-yl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00023 mM
(2S)-2-[[(3aS,6S,6aR)-4-(5-methoxy[1,3]thiazolo[5,4-b]-pyridin-2-yl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00087 mM
(2S)-2-[[(3aS,6S,6aR)-4-(6-ethylcarboxylate-1,2-benzothiazol-2-yl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]-pyrrol-1(2H)yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00035 mM
(2S)-2-[[(3aS,6S,6aR)-4-(6-fluoro-1,3-benzothiazol-2-yl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00036 mM
(2S)-2-[[(3aS,6S,6aR)-4-(6-methoxy-1,3-benzothiazol-2-yl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00022 mM
(2S)-2-[[(3aS,6S,6aR)-4-(cyclopropylcarbonyl)-6-meth-yl5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropoxyphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00018 mM
(2S)-2-[[(3aS,6S,6aR)-4-(cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(1-naphthyl)pyrrolidine-1-carboxamide
-
IC50: 0.00065 mM
(2S)-2-[[(3aS,6S,6aR)-4-(cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(2-isopropylphenyl)pyrrolidine-1-carboxamide
-
0.00047 mM
(2S)-2-[[(3aS,6S,6aR)-4-(cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(3-chlorophenyl)pyrrolidine-1-carboxamide
-
IC50: 0.0014 mM
(2S)-2-[[(3aS,6S,6aR)-4-(cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-chlorophenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00026 mM
(2S)-2-[[(3aS,6S,6aR)-4-(cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.0002 mM
(2S)-2-[[(3aS,6S,6aR)-4-(cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-propoxyphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00021 mM
(2S)-2-[[(3aS,6S,6aR)-4-(cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-[3-(trifluoromethyl)phenyl]pyrrolidine-1-carboxamide
-
0.00059 mM
(2S)-2-[[(3aS,6S,6aR)-4-(cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-[4-(trifluoromethyl)phenyl]pyrrolidine-1-carboxamide
-
IC50: 0.00023 mM
(2S)-2-[[(3aS,6S,6aR)-4-[(-cis-2,3-dimethylcyclopropyl)-cis-carbonyl]-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
-
(2S)-2-[[(3aS,6S,6aR)-4-[(-cis-2,3-dimethylcyclopropyl)-cis-carbony]-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.0003 mM
(2S)-2-[[(3aS,6S,6aR)-4-[(-cis-2,3-dimethylcyclopropyl)-trans-carbonyl]-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.0018 mM
(2S)-2-[[(3aS,6S,6aR)-4-[5-[(difluoromethyl)sulfonyl]-1,3-benzothiazol-2-yl]-6-methyl-5-oxohexahydropyrrolo-[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)-pyrrolidine-1-carboxamide
-
IC50: 0.00021 mM
(2S)-2-[[(3aS,6S,6aR)-4-[6-(hydroxymethyl)-1,3-benzothiazol-2-yl]-6-methyl-5-oxohexahydropyrrolo[3,2-b]-pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00031 mM
(2S)-2-[[(3aS,6S,6aR)-6-methyl-4-(4-nitrophenyl)-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.0087 mM
(2S)-2-[[(3aS,6S,6aR)-6-methyl-4-(6-nitro-1,3-benzothiazol-2-yl)-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]-carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00039 mM
(2S)-2-[[(3aS,6S,6aR)-6-methyl-5-oxo-4-(1,3-thiazol-2-yl)hexahydropyrrolo[3,2-b]pyrrol-1(2H)yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.0015 mM
(2S)-2-[[(3aS,6S,6aR)-6-methyl-5-oxo-4-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]hexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: above 0.02 mM
(2S)-2-[[(3aS,6S,6aR)-6-methyl-5-oxo-4-[1,3]thiazolo-[5,4-b]pyridin-2-ylhexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00029 mM
(2S)-2-[[(3aS,6S,6aR)-6-methyl-5-oxo-4-[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]hexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]-N-(4-isopropylphenyl)pyrrolidine-1-carboxamide
-
IC50: 0.00046 mM
(3aR,6R,6aS)-4-Acetyl-6-methyl-5-oxohexahydropyrrolo-[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: above 1 mM
(3aS,6S,6aR)-4-(2-Etoxy-acetyl)-6-methyl-5-oxohexahydropyrrolo-[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 0.006 mM
(3aS,6S,6aR)-4-Acetyl-6-methyl-5-oxohexahydropyrrolo-[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 0.11 mM; IC50: 0.79 mM
(3R,3aS,6aR)-1-Acetyl-3-methyl-4-([(2S)-1-[(4-methylphenyl) sulfonyl]pyrrolidin-2-yl]carbonyl)hexahydropyrrolo[3,2-b]pyrrol-2-one
-
IC50: 0.159 mM
(3R,3aS,6aR)-1-Acetyl-4-[((2S)-1-[[5-(dimethylamino)-1-naphthyl] sulfonyl]pyrrolidin-2-yl)carbonyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: above 0.5 mM
(3R,3aS,6aR)-1-Acetyl-4-[[(2S)-1-benzoylpyrrolidin-2-yl]carbonyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2-one
-
IC50: above 0.5 mM
(3S,3aR,6aS)-1-(cyclopropylcarbonyl)-3-methyl-4-[[(2S)-(2-naphthylsulfonyl)pyrrolidin-2-yl]carbonyl]-hexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: below 0.00019 mM
(3S,3aR,6aS)-1-(cyclopropylcarbonyl)-3-methyl-4-[[(2S)-1-(1-naphthylsulfonyl)pyrrolidin-2-yl]carbonyl]-hexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.00037 mM
(3S,3aR,6aS)-1-(cyclopropylcarbonyl)-3-methyl-4-[[(2S)-1-(4-propoxybenzoyl)pyrrolidin-2-yl]carbonyl]-hexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.00054 mM
(3S,3aR,6aS)-1-(cyclopropylcarbonyl)-3-methyl-4-[[(2S)-1-[(4-propoxyphenyl)sulfonyl]pyrrolidin-2-yl]-carbonyl]hexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.00023 mM
(3S,3aR,6aS)-1-(cyclopropylcarbonyl)-3-methyl-4-[[(2S)1-(phenylsulfonyl)pyrrolidin-2-yl]carbonyl]-hexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.0018 mM
(3S,3aR,6aS)-1-(Cyclopropylcarbonyl)-4-([(2S)-1-[(3-isopropoxyphenyl)sulfonyl]pyrrolidin-2-yl]carbonyl)-3-methylhexahydropyrrolo[3,2-b]pyrrol-2-one
-
IC50: 0.065 mM
(3S,3aR,6aS)-1-(Cyclopropylcarbonyl)-4-[((2S)-1-[[5-(dimethylamino)-1-naphthyl]sulfonyl]pyrrolidin-2-yl)carbonyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2-one
-
IC50: 0.00034 mM
(3S,3aR,6aS)-1-(cyclopropylcarbonyl)-4-[[(2S)-1-(4-isopropylbenzoyl)pyrrolidin-2-yl]carbonyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)
-
IC50: 0.00039 mM
(3S,3aR,6aS)-1-(cyclopropylcarbonyl)-4-[[(2S)-1-[(3-isopropoxyphenyl)sulfonyl]pyrrolidin-2-yl]carbonyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.065 mM
(3S,3aR,6aS)-1-(cyclopropylcarbonyl)-4-[[(2S)-1-[(4-isopropoxyphenyl)sulfonyl]pyrrolidin-2-yl]carbonyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.0004 mM
(3S,3aR,6aS)-1-(cyclopropylcarbonyl)-4-[[(2S)-1-[(4-isopropylphenyl)sulfonyl]pyrrolidin-2-yl]carbonyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.00046 mM
(3S,3aR,6aS)-1-(cyclopropylcarbonyl)-4-[[(2S)-1-[[5-(dimethylamino)-1-naphthyl]sulfonyl]pyrrolidin-2-yl]-carbonyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.00034 mM
(3S,3aR,6aS)-1-(cyclopropylcarbonyl)-4-[[(2S)-1-[[6-(dimethylamino)-1-naphthyl]sulfonyl]pyrrolidin-2-yl]-carbonyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.0011 mM
(3S,3aR,6aS)-1-Acetyl-3-methyl-4-([(2S)-1-[(4-methylphenyl) sulfonyl]pyrrolidin-2-yl]carbonyl)hexahydropyrrolo-[3,2-b]pyrrol-2-one
-
IC50: 0.014 mM
(3S,3aR,6aS)-1-Acetyl-4-[((2S)-1-[[5-(dimethylamino)-1-naphthyl] sulfonyl]pyrrolidin-2-yl)carbonyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.00054 mM
(3S,3aR,6aS)-1-Acetyl-4-[[(2S)-1-benzoylpyrrolidin-2-yl]carbonyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.05 mM
(3S,3aR,6aS)-4-[[(2S)-1-(1,1'-biphenyl-4-ylcarbonyl)-pyrrolidin-2-yl]carbonyl]-1-(cyclopropylcarbonyl)-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.0003 mM
(3S,3aR,6aS)-4-[[(2S)-1-(4-chlorobenzoyl)pyrrolidin-2-yl]carbonyl]-1-(cyclopropylcarbonyl)-3-methylhexahydropyrrolo[3,2-b]pyrrol-1(2H)-one
-
IC50: 0.0014 mM
(3S,3aR,6aS)-4-[[(2S)-1-(benzylsulfonyl)pyrrolidin-2-yl]carbonyl]-1-(cyclopropylcarbonyl)-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.0021 mM
(3S,3aR,6aS)-4-[[(2S)-1-[(4-chlorophenyl)sulfonyl]pyrrolidin-2-yl]carbonyl]-1-(cyclopropylcarbonyl)-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: 0.00084 mM
(3S,3aR,6aS)-4-[[(2S)-1-[(5-chloro-3-methyl-1-benzothien-2-yl)carbonyl]pyrrolidin-2-yl]carbonyl]-1-(cyclopropylcarbonyl)-3-methylhexahydropyrrolo[3,2]pyrrol-2(1H)-one
-
IC50: 0.00019 mM
2-[2-(3,3-Dimethyl-butanoylamino)-3,3-dimethyl-butanoylamino]-N4,N4-dimethyl-N1-(1-methyl-2-oxo-propyl)-succinamide
-
-
2-[2-(3,3-Dimethyl-butanoylamino)-3,3-dimethyl-butanoylamino]-N4,N4-dimethyl-N1-(3,3,3-trifluoro-1-methyl-2-oxo-propyl)-succinamide
-
-
2-[2-(3,3-Dimethyl-butanoylamino)-3,3-dimethyl-butanoylamino]-N4,N4-dimethyl-N1-(3,3,4,4,4-pentafluoro-1-methyl-2-oxo-butyl)-succinamide
-
-
3-[((2S)-2-[[(3aS,6S,6aR)-4-(Cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl]pyrrolidin-1-yl)sulfonyl]-N,N-dimethylbenzamide
-
IC50: 0.00014 mM
3-[[((2S)-2-[[(3aS,6S,6aR)-4-(Cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]-carbonyl]pyrrolidin-1-yl)sulfonyl]methyl]-N,N-dimethylbenzamide
-
IC50: 0.0022 mM
4-(2-Etoxy-acetyl)-6-methyl-5-oxohexahydropyrrolo-[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 0.013 mM
Ac-Gly-Val-Val-Asn-Ala chloromethyl ketone
-
-
-
ac-VVNASC
-
Ki: 1.52 mM
ac-VVNASCR
-
Ki: 0.628 mM
ac-VVNASCRL
-
Ki: 0.390 mM
BI31
-
50% inhibitory at 0.0017 mM. Increasing inhibitor concentrations in cells expressing the active protease correlate with increasing cell proliferation
BI36
-
50% inhibitory at 0.0005 mM. Increasing inhibitor concentrations in cells expressing the active protease correlate with increasing cell proliferation
diisopropyl fluorophosphate
Herpes simplex virus
-
-
GVVNAACRLA
-
Ki: 0.072 mM
GVVNASCRLA
-
Ki: 0.225 mM
monobactam inhibitors
-
beta-lactam derivatives with a carbon side-chain at C4 and a urea function at N1
-
N-[(1S)-2-[rel-(3aS,6S,6aR)-4-(Cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]-1-methyl-2-oxoethyl]-5-(dimethylamino)naphthalene-1-sulfonamide
-
IC50: 0.007 mM
N-[2-benzyl-4-(1H-tetrazol-5-yl)phenyl]-6-(cyclohexylmethyl)pyridine-2-carboxamide
N-[2-benzyl-4-[(methylsulfonyl)carbamoyl]phenyl]-6-(cyclohexylmethyl)pyridine-2-carboxamide
N-[2-[rel-(3aS,6S,6aR)-4-(Cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]-2-oxoethyl]-5-(dimethylamino)-N-methylnaphthalene-1-sulfonamide
-
IC50: above 0.1 mM
N1-(2-Benzylcarbamoyl-1-methyl-2-oxo-ethyl)-2-[2-(3,3-dimethyl-butanoylamino)-3,3-dimethyl-butanoylamino]-N4,N4-dimethyl-succinamide
-
-
rel-(3aS,6R,6aR)-3-methyl-2-oxo-hexahydro-pyrrolo-[3,2-b]pyrrolo-1,4-dicarboxylic acid 4-benzyl ester 1-methyl ester
-
0.5 mM, 7.9% inhibition after 15 min
rel-(3aS,6R,6aR)-4-acetoxyacetyl-6-methyl-5-oxohexahydro-pyrrolo[3,2-b]pyrrolo-1-carboxylic acid benzyl ester
-
IC50: 0.805 mM
rel-(3aS,6R,6aR)-4-acetyl-6-methyl-5-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 1.8 mM, 0.5 mM, 15.4% inhibition after 15 min
rel-(3aS,6R,6aR)-4-methanesulfonyl-6-methyl-5-oxohexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
0.5 mM, 15% inhibition after 15 min
rel-(3aS,6S,6aR)-4-(2,2-Dimethylpropanoyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: above 0.5 mM
rel-(3aS,6S,6aR)-4-(2,4-Dinitrophenyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: above 0.5 mM
rel-(3aS,6S,6aR)-4-(2-Hydroxy-3-phenoxypropyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: above 0.5 mM
rel-(3aS,6S,6aR)-4-(3-Hydroxypropanoyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 0.133 mM
rel-(3aS,6S,6aR)-4-(4-Methoxybenzoyl)-6-methyl-5-oxohexahydropyrrolo [3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: above 0.5 mM
rel-(3aS,6S,6aR)-4-(Bicyclo[4.2.0]octa-1,3,5-trien-7-ylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 0.0115 mM
rel-(3aS,6S,6aR)-4-(cis-2,3-Dimethylcyclopropanecarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 0.072 mM
rel-(3aS,6S,6aR)-4-(cyclobutylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 0.032 mM
rel-(3aS,6S,6aR)-4-(Cyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 0.009 mM
rel-(3aS,6S,6aR)-4-(Dimethoxyphosphoryl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: above 0.5 mM
rel-(3aS,6S,6aR)-4-(Hydroxymethyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: above 0.5 mM
rel-(3aS,6S,6aR)-4-(trans-2,3-Dimethylcyclopropylcarbonyl)-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: above 0.1 mM
rel-(3aS,6S,6aR)-4-Formyl-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 0.398 mM
rel-(3aS,6S,6aR)-4-Isobutyryl-6-methyl-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 0.126 mM
rel-(3aS,6S,6aR)-6-Methyl-4-(methylthio)-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: above 0.5 mM
rel-(3aS,6S,6aR)-6-Methyl-4-[(2-methylcyclopropyl)-carbonyl]-5-oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 0.01 mM
rel-(3aS,6S,6aR)-6-Methyl-5-oxo-4-(1H-pyrrol-1-ylcarbonyl)-hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: 0.25 mM
rel-(3aS,6S,6aR)-6-Methyl-5-oxo-4-(2,2,3,3-tetramethylcyclopropylcarbonyl) hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: above 0.5 mM
rel-(3aS,6S,6aR)-6-Methyl-5-oxo-4-[(1E)-3-oxobut-1-enyl]-hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester
-
IC50: above 0.5 mM
rel-(3S,3aR,6aS)-1-(Cyclopropylcarbonyl)-4-[(1-[[5-(dimethylamino)-1-naphthyl]sulfonyl]piperidin-2-yl)carbonyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
-
IC50: above 0.013 mM
rel-(3S,3aR,6aS)-1-Acetyl-3-methyl-4-(2-oxo-3-phenylpropyl) hexahydropyrrolo[3,2-b]pyrrol-2-one
-
IC50: 0.079 mM
rel-(3S,3aR,6aS)-1-Acetyl-3-methyl-4-(phenoxyacetyl)-hexahydropyrrolo[3,2-b]pyrrol-2-one
-
IC50: 0.063 mM
rel-(3S,3aR,6aS)-1-Acetyl-3-methyl-4-[(1-methyl-1Hpyrrol-2-yl)(oxo)acetyl]hexahydropyrrolo[3,2-b]pyrrol-2-one
-
IC50: 0.005 mM
rel-(3S,3aR,6aS)-1-Acetyl-3-methyl-4-[(2-phenylethyl)-sulfonyl]hexahydropyrrolo[3,2-b]pyrrol-2-one
-
IC50: 0.045 mM
rel-(3S,3aR,6aS)-1-Acetyl-4-[2-(5-fluoro-2-methyl-1Hindol-3-yl)acetyl]-3-methylhexahydropyrrolo[3,2-b]pyrrol-2-one
-
IC50: 0.006 mM
trans-2-oxo-hexahydro-pyrrolo[3,2-b]pyrrolo-1,4-dicarboxylic acid 4-benzyl ester 1 tert butyl ester
-
0.5 mM, 6.3% inhibition after 15 min
VVNASCRL
-
Ki: 0.699 mM
additional information
-